Literature DB >> 8454743

3D TOF MR angiography of cerebral arteriovenous malformations after radiosurgery.

H U Kauczor1, R Engenhart, G Layer, A H Gamroth, B Wowra, L R Schad, W Semmler, G van Kaick.   

Abstract

To investigate the potential of three-dimensional time-of-flight MR angiography (MRA) to complement SE imaging, 18 patients with intracerebral arteriovenous malformations were prospectively followed after undergoing radiosurgery. Vessel occlusion after stereotaxic single high dose radiotherapy develops slowly. The MRA detected signs of nidus obliteration earlier and with a higher sensitivity than did SE imaging. Six months after radiosurgery, MRA showed a reduction of the nidus flow signals in nine patients and after 1 year it showed reduction in 15 of the 18 patients. As shown by MRA, the loss of flow signals was related to a reduction of the nidus size in 4 patients after 6 months and in 11 after 1 year. The SE imaging revealed a reduction of the nidus size in only two patients after 6 months and in eight after 1 year. The signal intensity of the feeding arteries was reduced in nine patients and that of the draining veins was reduced in six. The T2-weighted images exhibited white matter lesions in eight patients after 1 year. For complete follow-up, SE imaging should be performed together with MRA.

Entities:  

Mesh:

Year:  1993        PMID: 8454743     DOI: 10.1097/00004728-199303000-00005

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  2 in total

1.  Detection of residual brain arteriovenous malformations after radiosurgery: diagnostic accuracy of contrast-enhanced three-dimensional time of flight MR angiography at 3.0 Tesla.

Authors:  Kyoung Eun Lee; Choong Gon Choi; Jin Woo Choi; Byung Se Choi; Deok Hee Lee; Sang Joon Kim; Do Hoon Kwon
Journal:  Korean J Radiol       Date:  2009-06-24       Impact factor: 3.500

2.  Magnetic Resonance Imaging-Based Robotic Radiosurgery of Arteriovenous Malformations.

Authors:  Tobias Greve; Felix Ehret; Theresa Hofmann; Jun Thorsteinsdottir; Franziska Dorn; Viktor Švigelj; Anita Resman-Gašperšič; Joerg-Christian Tonn; Christian Schichor; Alexander Muacevic
Journal:  Front Oncol       Date:  2021-03-09       Impact factor: 6.244

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.